Phospholipase A2 group XV activity during cardiopulmonary bypass surgery
Mario Navarrete(Health Sciences Centre), Julie Ho(Health Sciences Centre), Peter Nickerson(Shared Services Canada), Fok V. Chan(Echelon Biosciences), John A. Wilkins(University of Manitoba), Bo Ye(Fudan University)
Cited by 2
Related Papers
The Banff 97 working classification of renal allograft pathology
|Kidney International|1999|3.1k
The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials
|American Journal of Transplantation|2017|1k
The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody-mediated rejection
|American Journal of Transplantation|2020|809
Consensus Guidelines on the Testing and Clinical Management Issues Associated With HLA and Non-HLA Antibodies in Transplantation
|Transplantation|2012|777
National Conference to Assess Antibody-Mediated Rejection in Solid Organ Transplantation
|American Journal of Transplantation|2004|457